stoxline Quote Chart Rank Option Currency Glossary
  
Medtronic plc (MDT)
82.23  0.28 (0.34%)    06-12 16:00
Open: 82.27
High: 82.93
Volume: 4,822,969
  
Pre. Close: 81.95
Low: 81.93
Market Cap: 107,831(M)
Technical analysis
2024-06-12 4:23:34 PM
Short term     
Mid term     
Targets 6-month :  98.09 1-year :  100.64
Resists First :  83.98 Second :  86.16
Pivot price 82.42
Supports First :  80.45 Second :  66.94
MAs MA(5) :  82.74 MA(20) :  83.11
MA(100) :  83.72 MA(250) :  82.1
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  36.3 D(3) :  43.8
RSI RSI(14): 48.2
52-week High :  91 Low :  68.83
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MDT ] has closed above bottom band by 46.1%. Bollinger Bands are 6.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 82.97 - 83.38 83.38 - 83.79
Low: 80.95 - 81.38 81.38 - 81.81
Close: 81.55 - 82.22 82.22 - 82.9
Company Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Headline News

Wed, 12 Jun 2024
Medtronic PLC stock rises Wednesday, still underperforms market - MarketWatch

Wed, 12 Jun 2024
MGO One Seven LLC Sells 928 Shares of Medtronic plc (NYSE:MDT) - Defense World

Wed, 12 Jun 2024
Calculating The Intrinsic Value Of Medtronic plc (NYSE:MDT) - Yahoo Finance

Wed, 12 Jun 2024
Medtronic plc (NYSE:MDT) CEO Geoffrey Martha Sells 19113 Shares - Defense World

Wed, 12 Jun 2024
Brokerages Set Medtronic plc (NYSE:MDT) Price Target at $93.00 - MarketBeat

Tue, 11 Jun 2024
Medtronic plc (MDT) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 1,310 (M)
Shares Float 1,310 (M)
Held by Insiders 0.1 (%)
Held by Institutions 86.8 (%)
Shares Short 15,330 (K)
Shares Short P.Month 12,390 (K)
Stock Financials
EPS 2.75
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 38.29
Profit Margin 11.3 %
Operating Margin 21.6 %
Return on Assets (ttm) 4.4 %
Return on Equity (ttm) 7.2 %
Qtrly Rev. Growth 0.5 %
Gross Profit (p.s.) 0
Sales Per Share 24.7
EBITDA (p.s.) 6.95
Qtrly Earnings Growth -44.3 %
Operating Cash Flow 6,790 (M)
Levered Free Cash Flow 12,180 (M)
Stock Valuations
PE Ratio 29.79
PEG Ratio 3.4
Price to Book value 2.14
Price to Sales 3.32
Price to Cash Flow 15.86
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android